SHUTTLE PHARMACEUTICALS HOLDINGS, INC.

Profile

Company Names

SHUTTLE PHARMACEUTICALS HOLDINGS, INC.

Addresses

401 PROFESSIONAL DRIVE, SUITE 260, GAITHERSBURG, MD 20879

401 PROFESSIONAL DRIVE, SUITE 260, GAITHERSBURG, MD 20879

ONE RESEARCH COURT, SUITE 450, ROCKVILLE, MD 20850

ONE RESEARCH COURT, SUITE 450, ROCKVILLE, MD 20850

Phone Numbers

(240) 403-4212
240-403-4212

 

Entity Type:

CORPORATION

Industry:

OTHER TECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$23,397,498.00

Number of Funding Rounds:

9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2026-04-30 
$9,955,000.00 
$9,955,000.00 
$0.00 
Equity 
8
2025-11-03 
$2,499,998.00 
$2,500,624.00 
$626.00 
 
7
2025-06-20 
$4,250,000.00 
$4,250,000.00 
$0.00 
Equity 
6
2024-10-14 
$790,000.00 
$1,300,000.00 
$510,000.00 
 
5
2023-01-11 
$4,000,000.00 
$4,000,000.00 
$0.00 
 
4
2022-08-01 
$125,000.00 
$500,000.00 
$375,000.00 
Debt 
3
2022-02-08 
$365,000.00 
$2,000,000.00 
$1,635,000.00 
Debt 
2
2021-12-28 
$500,000.00 
$500,000.00 
$0.00 
Debt 
1
2018-08-01 
$912,500.00 
INDEFINITE 
INDEFINITE 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
WILLIAM 
 
ADKINS 
DIRECTOR
MILTON 
 
BROWN 
DIRECTOR, EXECUTIVE OFFICER
ADAM 
 
CHAMBERS 
DIRECTOR
PETER 
 
DRITSCHILLO 
EXECUTIVE OFFICER
ANATOLY 
 
DRITSCHILO 
EXECUTIVE OFFICER, DIRECTOR
ANATOLY 
M.D. 
DRITSCHILO 
EXECUTIVE OFFICER, DIRECTOR
PETER 
 
DRITSCHILO 
EXECUTIVE OFFICER, DIRECTOR
BETTE 
 
JACOBS 
DIRECTOR
MIRA 
 
JUNG 
EXECUTIVE OFFICER, DIRECTOR
YUYING 
 
LIANG 
EXECUTIVE OFFICER
ANGEL 
 
LIRIANO 
DIRECTOR
TIMOTHY 
 
LORBER 
EXECUTIVE OFFICER
OLEH 
 
NABYT 
DIRECTOR
SACHIN 
 
PATHIGODA 
DIRECTOR
TYVIN 
 
RICH 
EXECUTIVE OFFICER
STEVEN 
 
RICHARDS 
DIRECTOR
JOSH 
 
SCHAFER 
DIRECTOR
JOSHUA 
 
SCHAFER 
DIRECTOR
GEORGE 
 
SCORCIS 
DIRECTOR
CHRIS 
 
SENANAYAKE 
DIRECTOR
RYAN 
 
TRASOLINI 
EXECUTIVE OFFICER
JOSEPH 
 
TUNG 
DIRECTOR
MICHAEL 
 
VANDER HOEK 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER TECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2026-04-30 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2025-11-03 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-06-20 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2024-10-14 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2023-01-11 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2022-08-01 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2022-02-08 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2021-12-28 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
E.F. HUTTON + CO.
NONE
NONE
WESTPARK CAPITAL, INC.
WESTPARK CAPITAL, INC.
WESTPARK CAPITAL, INC.
NONE
NONE
BOUSTEAD SECURITIES, LLC